Oligofastx is a project born from a need: to offer a therapeutic pathway based on the development of specific oligonucleotides for certain rare diseases for which there is no solution at the moment. I feel this is our leit-motiv and sign of identity, we could not miss, of course, to join the celebration of Rare […]
Author Archives: oligofastx
If there is one word that distinguishes OLIGOFASTX and its philosophy, it is innovation. Thanks to our research efforts, we are able to advance our objective, which is none other than to improve the quality of life of patients affected by rare diseases that have no treatment. And this desire for innovation leads us to […]
Since 2015, the International Day of Women and Girls in Science has been celebrated every February 11.. Proclaimed by the UN, the main objective of this day is to achieve greater participation and inclusion of women and girls in the world of science and technology and break the gender gap that exists in some countries. […]
As it could not be otherwise, from Oligofastx we join in the celebration of the World Cancer Day, February 4, promoted by The World Cancer Society World Health Organization the International Agency for Research on Cancer (IARC) and the International Union Against Cancer (UICC) with the aim of raising awareness and mobilizing society to advance […]
Leber’s congenital amaurosis (LCA) is an eye disease that primarily affects the retina, the inner eye tissue on which images are projected and where light signals are converted into electrical impulses reaching the brain and generating vision. It is described as the sudden loss of vision in one of the two eyes due to the […]
Leber’s congenital amaurosis (LCA) is an eye disease that primarily affects the retina, the inner eye tissue on which images are projected and where light signals are converted into electrical impulses reaching the brain and generating vision. It is described as the sudden loss of vision in one of the two eyes due to the […]
The last few years have been a true revolution in terms of discoveries and initiatives linked to the world of oligonucleotides, and all eyes and hopes continue to focus in the same direction in the new year 2023. It is clear that the research being carried out in the scientific world is yielding results. In […]
The last few years have been a true revolution in terms of discoveries and initiatives linked to the world of oligonucleotides, and all eyes and hopes continue to focus in the same direction in the new year 2023. It is clear that the research being carried out in the scientific world is yielding results. In […]
Cancer cachexia is a complex metabolic syndrome characterized by marked loss of body weight, anorexia, asthenia, sarcopenia, and anemia. It is the most common manifestation of advanced malignant cancer, leading to death. Approximately half of all cancer patients experience cachexia and the prevalence is over 80% in terminally ill patients, with cachexia being responsible for […]
Perhaps the definition is not the most accurate, but in reality a rare disease does nothing more than denominate a pathology that has not yet been studied, analyzed and against which there is, for the time being, no solution. The complexity of the processes to reach social development solutions for the improvement of patients’ quality […]
Español







